Example: Heart Attack

Clinical Trials on Macular Degeneration

Total 1749 results

NCT04549935

Recruiting

The PRIME Study: A Randomized, Controlled, Prospective Study

Conditions: Patient Preference; Patient Outcomes; Post-Operative Inflammation; Grade of Post-Operative Cystoid Macular Edema; Rate of Post-Operative Cystoid Macular Edema
NCT04543331

Not yet recruiting

Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration

Conditions: Neovascular Age-related Macular Degeneration (nAMD)
NCT04544553

Completed

Barriers to Eye Screening for People With Diabetes in India

Conditions: Diabetic Macular Edema
NCT04537143

Not yet recruiting

Image Biomarkers for Progression of AMD

Conditions: AMD
NCT04537884

Recruiting

Safety and Tolerability Study of UBX1325 in Patients With Diabetic Macular Edema

Conditions: Diabetic Macular Edema
NCT04527107

Recruiting

A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

Conditions: Diabetes Mellitus; Diabetic Retinopathy; Diabetic Macular Edema
NCT04527523

Not yet recruiting

Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet Stripping Only

Conditions: Cystoid Macular Edema; Fuchs Dystrophy
NCT04522167

Recruiting

Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration

Conditions: Neovascular Age-related Macular Degeneration
NCT04522999

Recruiting

Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular Degeneration

Conditions: Age Related Macular Degeneration
NCT04516278

Not yet recruiting

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Conditions: Age-related Macular Degeneration; Neovascular Age-related Macular Degeneration; Wet Macular Degeneration; BRVO - Branch Retinal Vein Occlusion; Diabetic Macular Edema
NCT04514653

Recruiting

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Conditions: Neovascular Age-Related Macular Degeneration (nAMD)
NCT04511936

Not yet recruiting

Microcurrent Stimulation for Dry Age-related Macular Degeneration

Conditions: Dry Age-related Macular Degeneration
NCT04505306

Completed

Short-pulse Subthreshold vs Infrared Micropulse for Diabetic Macular Edema

Conditions: Diabetic Macular Edema
NCT04504123

Not yet recruiting

MMP-9 Inhibition for Recalcitrant Wet AMD

Conditions: Exudative Macular Degeneration; Wet Age-related Macular Degeneration
NCT04501367

Not yet recruiting

Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.

Conditions: Vitrectomy; Macular Pucker; Retinal Edema
NCT04499703

Not yet recruiting

Evaluation of the Retinal Health Monitoring System Thickness Module

Conditions: Macular Edema; Macular Degeneration
NCT04489511

Not yet recruiting

Study of STG-001 in Subjects With Stargardt Disease

Conditions: Stargardt Disease-1
NCT04486963

Recruiting

A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects

Conditions: Age-related Macular Degeneration
NCT04482465

Completed

Omega 3 and Vitamin D Dosage in a Population With Moderate to High Risk of AMD

Conditions: Age-related Macular Degeneration; Vitamin D Deficiency
NCT04480463

Not yet recruiting

A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD)

Conditions: Wet Age-related Macular Degeneration; Neovascular Age-related Macular Degeneration
NCT04472039

Active, not recruiting

Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling

Conditions: Macular Edema, Cystoid
NCT04469595

Recruiting

A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)

Conditions: Diabetic Macular Edema
NCT04468152

Completed

Advanced Glycation End Products Are Associated With Diabetic Macular Edema

Conditions: Diabetic Macular Edema; Diabetes Mellitus, Type 2
NCT04468373

Terminated

Study of WA-NG (NG-IMT) Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration

Conditions: Age Related Macular Degeneration
NCT04468997

Recruiting

The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)

Conditions: Wet Age-related Macular Degeneration
NCT04469140

Recruiting

Non Exudative AMD Imaged With SS-OCT- Extension

Conditions: Dry Macular Degeneration
NCT04465955

Recruiting

A Study of NGM621 in Participants With Geographic Atrophy

Conditions: Geographic Atrophy
NCT04464694

Not yet recruiting

Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema

Conditions: Proliferative Diabetic Retinopathy; Diabetic Macular Edema
NCT04458012

Enrolling by invitation

Epidemiological Study of Dry Eye Disease in Stavanger: Dry Eye Disease in Patients Treated With Intravitreal Injections

Conditions: Dry Eye
NCT04455399

Not yet recruiting

Time Efficiency Comparison of Two IntraVitreal Injection Techniques

Conditions: Neovascular Age-related Macular Degeneration; Diabetic Macular Edema; Retinal Vein Occlusion With Macular Edema; Uveitic Macular Edema; Choroidal Neovascularization
NCT04450329

Recruiting

A Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Conditions: Neovascular Age-related Macular Degeneration
NCT04448496

Recruiting

Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema

Conditions: Diabetic Retinopathy
NCT04444492

Not yet recruiting

Combination of Ranibizumab and Targeted Laser Photocoagulation

Conditions: Central Retinal Vein Occlusion With Macular Edema
NCT04439708

Not yet recruiting

Biomarkers and Choroidal Neovascularization

Conditions: Choroidal Neovascularization; Mineralocorticoid Excess
NCT04437368

Recruiting

EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

Conditions: Dry Age-related Macular Degeneration
NCT04435366

Recruiting

A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)

Conditions: Geographic Atrophy; Macular Degeneration
NCT04432831

Recruiting

A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema

Conditions: Diabetic Macular Edema
NCT04429503

Recruiting

Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease

Conditions: Diabetic Macular Edema; Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
NCT04428242

Withdrawn

Study Evaluating Retinal Health Monitoring System Thickness Module

Conditions: Macular Edema; Macular Degeneration
NCT04420923

Recruiting

Optimizing the Treatment Strategy for Age-related Macular Degeneration

Conditions: Wet Macular Degeneration
NCT04422899

Not yet recruiting

Effect of Intravitreally Administered AIV007 in Subjects With nAMD

Conditions: Neovascular Age-related Macular Degeneration
NCT04423718

Recruiting

Study to Gather Information on Safety and Use of High Dose Aflibercept Injection Into the Eye in Patients With an Age Related Eye Disorder That Causes Blurred Vision or a Blind Spot Due to Abnormal Blood Vessels That Leak Fluid Into the Light Sensitive Lining Inside the Eye

Conditions: Neovascular Age-Related Macular Degeneration
NCT04418427

Recruiting

ADVM-022 Intravitreal Gene Therapy for DME

Conditions: Diabetic Macular Edema; Diabetic Retinopathy
NCT04411693

Recruiting

Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema

Conditions: Diabetic Macular Edema
NCT04395859

Recruiting

Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents

Conditions: Age Related Macular Degeneration; Diabetic Macular Edema; Retinal Vein Occlusion
NCT04390126

Active, not recruiting

COVID-19 Related Lockdown Effects On Chronic Diseases

Conditions: Chronic Coronary Syndrome; Heart Failure; AMD and Macular Edema; Chronic Respiratory Failure; Hemophilia; Malignant Hemopathy; Multiple Sclerosis; Horton's Disease
NCT04387604

Completed

Effect of the Vitreous in Response to Intravitreal Injections of Ranibizumab for the Treatment of Diabetic Macular Edema

Conditions: Diabetic Macular Edema
NCT04377295

Completed

Evaluation of Retinal and Vascular Features in Radiation Maculopathy After Intravitreal Injections of Ranibizumab

Conditions: Radiation Maculopathy
NCT04370379

Recruiting

Trial to Evaluate the Safety and Tolerability of Repeated Intravitreal Injection of IBI302 in Neovascular AMD Patients

Conditions: Neovascular Age-related Macular Degeneration
NCT04358471

Not yet recruiting

Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Conditions: Dry Age-related Macular Degeneration; Geographic Atrophy; Gene Therapy; Intravitreal Injection

COOKIE SETTINGS

Clinical Trials on Macular Degeneration